Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,347 | 349,130 | 433,074 | 83,366 | 99,814 |
| Marketable Securities | 315,569 | 139,675 | 100,335 | 119,918 | 121,613 |
| Receivables | 5,515 | 3,243 | 1,717 | N/A | N/A |
| TOTAL | $494,323 | $496,777 | $540,225 | $208,249 | $227,089 |
| Non-Current Assets | |||||
| PPE Net | 32,308 | 20,710 | 15,932 | 11,896 | 11,419 |
| Investments And Advances | 0 | 13,233 | 0 | 16,139 | 39,440 |
| Other Non-Current Assets | 95,826 | 95,723 | 97,437 | 85,606 | 24,326 |
| TOTAL | $128,134 | $129,666 | $113,369 | $113,641 | $75,185 |
| Total Assets | $622,457 | $626,443 | $653,594 | $321,890 | $302,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,283 | 3,717 | 13,563 | 5,173 | 5,822 |
| Accrued Expenses | 15,564 | 14,782 | 11,618 | 11,770 | 14,697 |
| Other current liabilities | 39,218 | 16,245 | 3,160 | 3,160 | 2,808 |
| TOTAL | $85,564 | $54,195 | $45,322 | $24,924 | $27,806 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,144 | 17,121 | 14,626 | 2,923 | 2,787 |
| Other Non-Current Liabilities | 106,427 | 98,505 | 79,473 | 74,624 | 25,937 |
| TOTAL | $152,448 | $147,883 | $134,161 | $77,748 | $29,712 |
| Total Liabilities | $238,012 | $202,078 | $179,483 | $102,672 | $57,518 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,783 | 87,244 | 86,844 | 77,692 | 75,931 |
| Common Shares | 88 | 87 | 87 | 76 | 76 |
| Retained earnings | -556,932 | -503,821 | -445,137 | -417,065 | -383,545 |
| Other shareholders' equity | 73 | 315 | 626 | 145 | 25 |
| TOTAL | $384,445 | $424,365 | $474,111 | $219,218 | $244,756 |
| Total Liabilities And Equity | $622,457 | $626,443 | $653,594 | $321,890 | $302,274 |